 |
SPECIAL EDITIONDAY 5: ACHEMA 2015 DRAWS TO A CLOSE
ACHEMA is known as the world forum for chemical engineering and the process industry. As movers and shakers gather at Frankfurt am Main from 15–19 June to showcase their innovative technologies, new developments, products, and services, the editors of Pharmaceutical Technology Europe bring you updates from the exhibition floor in this special edition of show daily e-newsletters.
|
|
|
Subscribe Subscribers can enjoy each full issue of PharmTech Europe in print, or via PharmTech Europe apps.
subscription offers
|
|
|
|
|
ACHEMA NEWS
It’s the last day at ACHEMA! With a few more hours left before the show draws to a close, here's a brief summary of the key trends observed during the week.
/ read more /
The design of the shovel means that less drive power is required compared with a standard shovel, thus resulting in substantial energy savings.
/ read more /
Designed with safety standards in mind, flowtherm Ex incorporates a number of connectable sensors, such as vane wheel, vortex, thermal, Pt100, and other physical sensors with analog output, thereby allowing a range of applications.
/ read more /
Porvair has developed a 2-ml 96 round-well deep-well plate that enables scientists to use the full 2.00 ml well capacity.
/ read more /
Saint-Gobain Seals is featuring several sealing and polymer solutions at ACHEMA including the OmniSeal spring-energized seals for liquid chromatography and the Rulon wear components for pharmaceutical manufacturing equipment.
/ read more /
A Q&A with Ben Potenza from EquipNet about the advantages of active asset management and how it can maximize a company’s return on investment.
/ read more /
|
|
|
PHARMACEUTICAL MANUFACTURING EXPERTISE: FOCUS ON BIOPROCESSING AND STERILE MANUFACTURING
ACHEMA is a key event for many industries, including pharma. No doubt the processes involved in pharmaceutical manufacturing have significant impact on the quality and performance of the final drug product. Pharmaceutical Technology Europe has an extensive archive of pharmaceutical manufacturing features and our editors have handpicked some of our top articles to supplement your ACHEMA experience.
Risks associated with single-use technologies, such as product loss and sterility assurance, are magnified in the filling operation because of its closeness to the product in its final form. A thorough evaluation of the assembly design process, manufacture, and use can assist in identifying and mitigating these risks.
/ read more /
Residual hydrogen peroxide from the vapor-phase HP (VPHP) isolator decontamination process can diffuse into drug product, potentially resulting in significant protein oxidation and thus impacting product quality. The effect of absorbed VPHP on a lyophilized product, Protein Z, was studied by spiking experiments with different amounts of hydrogen peroxide and the stability of the lyophilized product was studied for up to six months.
/ read more /
|
|
|
|
|
